Figure 2From: A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition MRPA incidence rates in ICUs during and after the implementation of the restricted use of carbapenems. Bars: incidence rates (n° MRPA cases/1,000 patient-days). Line: DDD carbapenem use/1,000 patient-days.Back to article page